SNPMiner Trials by Shray Alag

SNPMiner SNPMiner Trials (Home Page)

Report for Clinical Trial NCT01439802

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

Transcesarean IUD Insertion: A Prospective Cohort Study

The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.

NCT01439802 Intrauterine Device Expulsion

1 Interventions

Name: Copper IUD placement at time Cesarean Delivery (Copper T 380A)

Description: Placement of Paragard IUD at time of Cesarean Delivery
Type: Device

Primary Outcomes

Description: Expulsion of IUDs placed at time of cesarean delivery

Measure: Expulsion

Time: 6 months postpartum

Secondary Outcomes

Description: Satisfaction of subjects who received an IUD at time of cesarean delivery will be measured with the Likert Scale.

Measure: Satisfaction

Time: 6 months postpartum

Purpose: Prevention

Allocation: Non-Randomized

Single Group Assignment

There is one SNP


1 T380A

After delivery of the placenta, a ParaGard® copper T380A IUD was inserted through the hysterotomy site. --- T380A ---

HPO Nodes